Akebia Therapeutics (AKBA) Accounts Payables (2013 - 2026)
Akebia Therapeutics' Accounts Payables came in at $9.42 million for Q2 2026, down 18.5% from $11.55 million a year earlier but up 12.4% from the prior quarter.
Powered by 
Analysis
Akebia Therapeutics (AKBA) Accounts Payables (2013 - 2026) Analysis & Trends
At the end of FY2025, Akebia Therapeutics' Accounts Payables was $21.19 million, up 39.6% from FY2024.
- Accounts Payables carries a five-year compound annual growth rate of -12.5% (FY2020 to FY2025).
- Going back by year, Accounts Payables was $15.18 million in FY2024 (+3.7%), $14.64 million in FY2023 (-18.8%), $18.02 million in FY2022 (-46.3%) and $33.59 million in FY2021 (-18.7%).
- The five-year range for quarterly Accounts Payables is $8.39 million (Q1 2026) to $33.59 million (Q4 2021).
- Year-over-year, Accounts Payables increased in five of the last eight quarters, with growth averaging 4.5%.
- The fastest year-over-year change in Accounts Payables over five years came in Q3 2024 (growth of 49.3%), and the weakest in Q3 2023 (a decline of 54.1%).
- Business Quant data shows AKBA's Accounts Payables at $8.39 million (Q1 2026), $21.19 million (Q4 2025) and $10.09 million (Q3 2025) in the three quarters before Q2 2026.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Accounts Payables (Qtr) |
|---|---|---|---|---|---|
| 1 | Johnson & Johnson | 638.12 Bn | 556.64 Bn | 17.26 Bn | 9.22 Bn |
| 2 | AbbVie | 462.60 Bn | 435.75 Bn | 12.70 Bn | 33.30 Bn |
| 3 | Merck | 358.70 Bn | 313.13 Bn | 12.21 Bn | 3.83 Bn |
| 4 | Novartis Ag | 272.16 Bn | 228.03 Bn | 11.24 Bn | 4.26 Bn |
| 5 | Astrazeneca | 250.36 Bn | 223.92 Bn | 12.86 Bn | -22.89 Bn |
| 6 | Amgen | 227.87 Bn | 183.27 Bn | 7.24 Bn | 2.87 Bn |
| 7 | Gilead Sciences | 184.97 Bn | 159.08 Bn | 6.22 Bn | 674.00 Mn |
| 8 | Pfizer | 162.61 Bn | 109.56 Bn | 10.94 Bn | 4.58 Bn |
| 9 | Vertex Pharmaceuticals | 132.45 Bn | 104.46 Bn | 2.84 Bn | 429.50 Mn |
| 10 | Akebia Therapeutics | 250.00 Mn | -419.48 Mn | 38.70 Mn | 9.42 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 9.42 Mn |
| Mar 31, 2026 | 8.39 Mn |
| Dec 31, 2025 | 21.19 Mn |
| Sep 30, 2025 | 10.09 Mn |
| Jun 30, 2025 | 11.55 Mn |
| Mar 31, 2025 | 12.66 Mn |
| Dec 31, 2024 | 15.18 Mn |
| Sep 30, 2024 | 13.49 Mn |
| Jun 30, 2024 | 10.11 Mn |
| Mar 31, 2024 | 11.88 Mn |
| Dec 31, 2023 | 14.64 Mn |
| Sep 30, 2023 | 9.04 Mn |
| Jun 30, 2023 | 11.78 Mn |
| Mar 31, 2023 | 12.58 Mn |
| Dec 31, 2022 | 18.02 Mn |
| Sep 30, 2022 | 19.71 Mn |
| Jun 30, 2022 | 24.94 Mn |
| Mar 31, 2022 | 19.47 Mn |
| Dec 31, 2021 | 33.59 Mn |
| Sep 30, 2021 | 28.81 Mn |
API Access
Akebia Therapeutics Accounts Payables API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=accounts-payables&ticker=AKBA&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "accounts-payables", "ticker": "AKBA", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=accounts-payables&ticker=AKBA&period=max&api_key=YOUR_API_KEY");
const data = await res.json();